H
Hareld M. C. Kemps
Researcher at Eindhoven University of Technology
Publications - 111
Citations - 2720
Hareld M. C. Kemps is an academic researcher from Eindhoven University of Technology. The author has contributed to research in topics: Medicine & Heart failure. The author has an hindex of 26, co-authored 84 publications receiving 1801 citations. Previous affiliations of Hareld M. C. Kemps include University of Amsterdam.
Papers
More filters
Journal ArticleDOI
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology:
Marco Ambrosetti,Ana Abreu,Ugo Corrà,Constantinos H. Davos,Dominique Hansen,Ines Frederix,Marie Christine Iliou,Roberto F E Pedretti,Jean-Paul Schmid,Carlo Vigorito,Heinz Völler,Mathias Wilhelm,Massimo F Piepoli,Birna Bjarnason-Wehrens,Thomas Berger,Alain Cohen-Solal,Véronique Cornelissen,Paul Dendale,Wolfram Doehner,Dan Gaita,Andreas B. Gevaert,Hareld M. C. Kemps,Nicolle Kraenkel,Jari A. Laukkanen,Miguel Mendes,Josef Niebauer,Maria Simonenko,Ann-Dorthe Zwisler +27 more
TL;DR: Secondary prevention through comprehensive cardiac rehabilitation has been recognized as the most cost-effective intervention to ensure favourable outcomes across a wide spectrum of cardiovascular ...
Journal ArticleDOI
Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: Results of the FIT@Home study
Jos J. Kraal,M. Elske van den Akker-van Marle,Ameen Abu-Hanna,Wim Stut,Niels Peek,Hareld M. C. Kemps +5 more
TL;DR: It is concluded that home-basedTraining with telemonitoring guidance can be used as an alternative to centre-based training for low-to-moderate cardiac risk patients entering cardiac rehabilitation and appears to be more cost-effective than centre- based training.
Journal ArticleDOI
The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiology.
Martijn Scherrenberg,Matthias Wilhelm,Dominique Hansen,Dominique Hansen,Heinz Völler,Véronique Cornelissen,Ines Frederix,Hareld M. C. Kemps,Paul Dendale +8 more
TL;DR: The present call for action paper gives an update of recent cardiac telerehabilitation studies and provides a practical guide for the setup of a comprehensive cardiac teleRehabilitation intervention during the COVID-19 pandemic.
Journal ArticleDOI
Cardiac Rehabilitation Availability and Density around the Globe.
Karam Turk-Adawi,Marta Supervia,Marta Supervia,Francisco Lopez-Jimenez,Ella Pesah,Rongjing Ding,Raquel Rodrigues Britto,Birna Bjarnason-Wehrens,Wayne Derman,Ana Abreu,Abraham Samuel Babu,Claudia Victoria Anchique Santos,Seng Khiong Jong,Lucky Cuenza,Tee Joo Yeo,Dawn C. Scantlebury,Karl Andersen,Graciela Gonzalez,Vojislav Giga,Dusko Vulic,Eleonora Vataman,Jacqueline Cliff,Evangelia Kouidi,Ilker Yagci,Chul Kim,Briseida Benaim,Eduardo Rivas Estany,Rosalia Fernandez,Basuni Radi,Dan Gaita,Attila Simon,Ssu-Yuan Chen,Brendon Roxburgh,Juan Castillo Martin,L Maskhulia,Gerard Burdiat,Richard Salmon,Hermes Lomelí,Masoumeh Sadeghi,Eliška Sovová,Arto J. Hautala,Egle Tamuleviciute-Prasciene,Marco Ambrosetti,Lis Neubeck,Elad Asher,Hareld M. C. Kemps,Zbigniew Eysymontt,Stefan Farsky,Jo Hayward,Eva Prescott,Susan Dawkes,Claudio Santibáñez,Cecilia Zeballos,Bruno Pavy,Anna Kiessling,Nizal Sarrafzadegan,Nizal Sarrafzadegan,Carolyn Baer,Randal J. Thomas,Dayi Hu,Sherry L. Grace,Sherry L. Grace +61 more
TL;DR: This study ascertained CR availability, volumes and its drivers, and density globally, finding that capacity is grossly insufficient, such that most patients will not derive the benefits associated with participation.
Journal ArticleDOI
Cardiac rehabilitation and survival in a large representative community cohort of Dutch patients
Han de Vries,Hareld M. C. Kemps,Mariëtte M. van Engen-Verheul,Roderik A. Kraaijenhagen,Niels Peek +4 more
TL;DR: In a large and representative community cohort of Dutch patients with an ACS and/or intervention, CR was associated with a substantial survival benefit up to 4 years, present regardless of age, type of diagnosis, and type of intervention.